Literature DB >> 20963460

Voriconazole plasma levels in children are highly variable.

I Spriet1, K Cosaert, M Renard, A Uyttebroeck, I Meyts, M Proesmans, G Meyfroidt, J de Hoon, R Verbesselt, L Willems.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20963460     DOI： 10.1007/s10096-010-1079-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  11 in total

Review 1.  Antifungal therapeutic drug monitoring: established and emerging indications.

Authors:  David Andes; Andres Pascual; Oscar Marchetti
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

2.  Voriconazole-induced photosensitivity.

Authors:  Anurag N Malani; David M Aronoff
Journal:  Clin Med Res       Date:  2008-09-18

3.  Population pharmacokinetic analysis of voriconazole plasma concentration data from pediatric studies.

Authors:  Mats O Karlsson; Irja Lutsar; Peter A Milligan
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

4.  Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens.

Authors:  L Purkins; N Wood; P Ghahramani; K Greenhalgh; M J Allen; D Kleinermans
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

5.  Voriconazole pharmacokinetics and pharmacodynamics in children.

Authors:  Michael Neely; Teresa Rushing; Andrea Kovacs; Roger Jelliffe; Jill Hoffman
Journal:  Clin Infect Dis       Date:  2010-01-01       Impact factor: 9.079

6.  Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation.

Authors:  Isabel Spriet; Pieter Annaert; Philippe Meersseman; Greet Hermans; Wouter Meersseman; Rene Verbesselt; Ludo Willems
Journal:  J Antimicrob Chemother       Date:  2009-02-13       Impact factor: 5.790

7.  In vitro hepatic metabolism explains higher clearance of voriconazole in children versus adults: role of CYP2C19 and flavin-containing monooxygenase 3.

Authors:  Souzan B Yanni; Pieter P Annaert; Patrick Augustijns; Joseph G Ibrahim; Daniel K Benjamin; Dhiren R Thakker
Journal:  Drug Metab Dispos       Date:  2010-01       Impact factor: 3.922

8.  Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.

Authors:  Andres Pascual; Thierry Calandra; Saskia Bolay; Thierry Buclin; Jacques Bille; Oscar Marchetti
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

9.  Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration.

Authors:  Thomas J Walsh; Mats O Karlsson; Timothy Driscoll; Adriano G Arguedas; Peter Adamson; Xavier Saez-Llorens; Ajay J Vora; Antonio C Arrieta; Jeffrey Blumer; Irja Lutsar; Peter Milligan; Nolan Wood
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

Review 10.  Pediatric antifungal agents.

Authors:  Michael Cohen-Wolkowiez; Cassandra Moran; Daniel K Benjamin; Phillip B Smith
Journal:  Curr Opin Infect Dis       Date:  2009-12       Impact factor: 4.915
View more
  11 in total

1.  Therapeutic monitoring of voriconazole in children less than three years of age: a case report and summary of voriconazole concentrations for ten children.

Authors:  Elizabeth H Doby; Daniel K Benjamin; Anne J Blaschke; Robert M Ward; Andrew T Pavia; Paul L Martin; Timothy A Driscoll; Michael Cohen-Wolkowiez; Cassandra Moran
Journal:  Pediatr Infect Dis J       Date:  2012-06       Impact factor: 2.129

2.  Voriconazole monitoring in children with invasive fungal infections.

Authors:  Lyn Tucker; Tara Higgins; Eric F Egelund; Baiming Zou; Vini Vijayan; Charles A Peloquin
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Jan-Feb

Review 3.  Pediatric Clinical Pharmacology of Voriconazole: Role of Pharmacokinetic/Pharmacodynamic Modeling in Pharmacotherapy.

Authors:  Rajendra S Kadam; Johannes N Van Den Anker
Journal:  Clin Pharmacokinet       Date:  2016-09       Impact factor: 6.447

Review 4.  Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.

Authors:  Jessica K Roberts; Chris Stockmann; Jonathan E Constance; Justin Stiers; Michael G Spigarelli; Robert M Ward; Catherine M T Sherwin
Journal:  Clin Pharmacokinet       Date:  2014-07       Impact factor: 6.447

Review 5.  Pharmacokinetics and pharmacodynamics of antifungals in children and their clinical implications.

Authors:  Chris Stockmann; Jonathan E Constance; Jessica K Roberts; Jared Olson; Elizabeth H Doby; Krow Ampofo; Justin Stiers; Michael G Spigarelli; Catherine M T Sherwin
Journal:  Clin Pharmacokinet       Date:  2014-05       Impact factor: 6.447

6.  Highly variable plasma concentrations of voriconazole in pediatric hematopoietic stem cell transplantation patients.

Authors:  Imke H Bartelink; Tom Wolfs; Martine Jonker; Marjolein de Waal; Toine C G Egberts; Tessa T Ververs; Jaap J Boelens; Marc Bierings
Journal:  Antimicrob Agents Chemother       Date:  2012-10-31       Impact factor: 5.191

Review 7.  The use of antifungal therapy in neonatal intensive care.

Authors:  Daniela Testoni; P Brian Smith; Daniel K Benjamin
Journal:  Clin Perinatol       Date:  2012-01-11       Impact factor: 2.642

Review 8.  Therapeutic drug monitoring for triazoles: A needs assessment review and recommendations from a Canadian perspective.

Authors:  Michel Laverdiere; Eric J Bow; Coleman Rotstein; Julie Autmizguine; Raewyn Broady; Gary Garber; Shariq Haider; Trana Hussaini; Shahid Husain; Philippe Ovetchkine; Jack T Seki; Yves Théorêt
Journal:  Can J Infect Dis Med Microbiol       Date:  2014 Nov-Dec       Impact factor: 2.471

9.  The effect of inflammation on voriconazole trough concentrations in children.

Authors:  Mendy Ter Avest; Anette Veringa; Edwin R van den Heuvel; Jos G W Kosterink; Elisabeth H Schölvinck; Wim J E Tissing; Jan-Willem C Alffenaar
Journal:  Br J Clin Pharmacol       Date:  2016-11-09       Impact factor: 4.335

10.  Impact of Inflammation on Cytochromes P450 Activity in Pediatrics: A Systematic Review.

Authors:  Camille Lenoir; Frédérique Rodieux; Jules A Desmeules; Victoria Rollason; Caroline F Samer
Journal:  Clin Pharmacokinet       Date:  2021-08-31       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.